May 16, 2023 07:20 AM EDT
Deals
R&D

Astel­las, Sony part­ner up for an­ti­body-drug con­ju­gate plat­form to cre­ate 'bet­ter per­form­ing' drugs

Katherine Lewin

News Reporter

Astel­las and Sony Cor­po­ra­tion have teamed up to de­vel­op a new an­ti­body-drug con­ju­gate plat­form that de­liv­ers drugs to the tar­get cells in a bid to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Sanofi, Ope­nAI, For­ma­tion Bio de­but pa­tient re­cruit­ing tool, will use in Phase 3 mul­ti­ple scle­ro­sis stud­ies

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

Maze's ALS spin­out Trace Neu­ro­science rais­es $101M for ALS and neu­ro work

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

No­var­tis pays $150M up­front to Schrödinger in new drug deal, ramps up soft­ware use

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times